Enterprise Value

344.8M

Cash

50.22M

Avg Qtr Burn

-11.36M

Short % of Float

0.98%

Insider Ownership

31.87%

Institutional Own.

52.36%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date